trial

Multi-center Imaging Genetics Studies in China

NCTId NCT02681822
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 10,000 (estimated)
Sponsored by Tianjin Medical University General Hospital
Primary completion 2019-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
10,000 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2015-11
Primary completion
2019-12
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
—

Sponsors

Tianjin Medical University General HospitalLead Sponsor
Tianjin Medical University Cancer Institute and HospitalCollaborator
Tianjin Medical University Second HospitalCollaborator
Tianjin First Central HospitalCollaborator
Pingjin Hospital,Logistics University of Chinese People's Armed Police ForcesCollaborator
School of Medical Imaging, Tianjin Medical UniversityCollaborator
Tianjin Huanhu HospitalCollaborator
Beijing HospitalCollaborator
Chinese PLA General HospitalCollaborator
Beijing Tongren HospitalCollaborator
Xuanwu Hospital, BeijingCollaborator
Peking Union Medical College HospitalCollaborator
Beijing Normal UniversityCollaborator
Chinese Academy of SciencesCollaborator
The Second Hospital of Hebei Medical UniversityCollaborator
The First Affiliated Hospital of Shanxi Medical UniversityCollaborator
Inner Mongolia Medical College HospitalCollaborator
The First Hospital of Jilin UniversityCollaborator
First Hospital of China Medical UniversityCollaborator
The First Affiliated Hospital of Dalian Medical UniversityCollaborator
RenJi HospitalCollaborator
Huashan HospitalCollaborator
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolCollaborator
Nanjing PLA General HospitalCollaborator
The First Affiliated Hospital with Nanjing Medical UniversityCollaborator
Xuzhou Medical UniversityCollaborator
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCollaborator
First Affiliated Hospital of Wenzhou Medical UniversityCollaborator
The First Affiliated Hospital of Anhui Medical UniversityCollaborator
Shan dong Medical Imaging Research InstituteCollaborator
Qilu Hospital of Shandong UniversityCollaborator
Yantai Yuhuangding HospitalCollaborator
Henan Provincial People's HospitalCollaborator
The First Affiliated Hospital of Zhengzhou UniversityCollaborator
Tongji HospitalCollaborator
Wuhan UniversityCollaborator
Xiangya Hospital of Central South UniversityCollaborator
Central South UniversityCollaborator
Guangdong Provincial People's HospitalCollaborator
The First Affiliated Hospital, Guangzhou University of Traditional Chinese MedicineCollaborator
South China Normal UniversityCollaborator
First Affiliated Hospital Xi'an Jiaotong UniversityCollaborator
Xijing HospitalCollaborator
Tang-Du HospitalCollaborator
LanZhou UniversityCollaborator
West China HospitalCollaborator
Second Affiliated Hospital of Wenzhou Medical UniversityCollaborator
University of Electronic Science and Technology of ChinaCollaborator
First Affiliated Hospital of Chongqing Medical UniversityCollaborator
Southwest Hospital, ChinaCollaborator
The University of Science and Technology of ChinaCollaborator
Guangdong No.2 Provincial People's HospitalCollaborator

Investigators

1
Chunshui Yu, PhDPrincipal Investigator

Sites

1 total
Tianjin, China

Facts & assertions

4 sourced
Enrollment
10,000
Phase
NA
Primary Completion Date
2019-12
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
Tianjin Medical University General Hospital
company
collaborator
Tianjin Medical University Cancer Institute and Hospital
company
Tianjin Medical University Second Hospital
company
indication
Alzheimer Disease
indication
Depressive Disorder, Major
indication
Schizophrenia
indication
investigator
Chunshui Yu, PhD
person